OAM
AMAG

Oxford Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Oxford Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-113,798
Closed -$1.39M – 1663
2019
Q4 		$1.39M Buy
113,798
+72,064
+173% +$788K 0.04% 641
2019
Q3 		$482K Buy
+41,734
New +$439K 0.01% 1277
2019
Q1 		– Sell
-77,942
Closed -$1.18M – 2137
2018
Q4 		$1.18M Buy
77,942
+44,975
+136% +$857K 0.03% 777
2018
Q3 		$664K Sell
32,967
-77,637
-70% -$1.77M 0.01% 1187
2018
Q2 		$2.23M Buy
110,604
+36,923
+50% +$817K 0.04% 605
2018
Q1 		$1.49M Sell
73,681
-23,235
-24% -$393K 0.03% 737
2017
Q4 		$1.3M Sell
96,916
-5,244
-5% -$79.1K 0.03% 800
2017
Q3 		$1.87M Sell
102,160
-40,947
-29% -$763K 0.04% 648
2017
Q2 		$2.63M Sell
143,107
-56,761
-28% -$1.12M 0.05% 477
2017
Q1 		$4.51M Buy
199,868
+91,588
+85% +$2.19M 0.11% 174
2016
Q4 		$3.77M Sell
108,280
-133,886
-55% -$4M 0.13% 149
2016
Q3 		$5.93M Buy
242,166
+65,424
+37% +$1.64M 0.18% 132
2016
Q2 		$4.23M Sell
176,742
-45,347
-20% -$1.04M 0.14% 184
2016
Q1 		$5.2M Buy
222,089
+97,068
+78% +$2.3M 0.15% 153
2015
Q4 		$3.77M Buy
+125,021
New +$4.04M 0.09% 245

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Oxford Asset Management's AMAG Position: Q1 2020 in Review

Oxford Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2020, closing a stake of 113,798 shares — an estimated $1.39M sold.

Oxford Asset Management first reported a position in AMAG in Q4 2015 and held it in 15 quarters. The position peaked at $5.93M in Q3 2016. 119 funds tracked by Wall St. Rank hold AMAG as of Q1 2020.

  • Oxford Asset Management reported no remaining AMAG Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 113,798 AMAG Pharmaceuticals shares in Q1 2020, an estimated $1.39M.
  • Oxford Asset Management first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 15 quarters.
  • Oxford Asset Management's AMAG Pharmaceuticals position peaked at $5.93M in Q3 2016.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.